ATE283065T1 - Mehrzweckvakzine gegen umhüllte viren - Google Patents

Mehrzweckvakzine gegen umhüllte viren

Info

Publication number
ATE283065T1
ATE283065T1 AT96913123T AT96913123T ATE283065T1 AT E283065 T1 ATE283065 T1 AT E283065T1 AT 96913123 T AT96913123 T AT 96913123T AT 96913123 T AT96913123 T AT 96913123T AT E283065 T1 ATE283065 T1 AT E283065T1
Authority
AT
Austria
Prior art keywords
mhc molecules
vaccine compositions
virus
vaccine against
cells
Prior art date
Application number
AT96913123T
Other languages
English (en)
Inventor
Donald L Morton
Original Assignee
Wayne John Cancer Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne John Cancer Inst filed Critical Wayne John Cancer Inst
Application granted granted Critical
Publication of ATE283065T1 publication Critical patent/ATE283065T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001111—Immunoglobulin superfamily
    • A61K39/001114—CD74, Ii, MHC class II invariant chain or MHC class II gamma chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96913123T 1995-04-24 1996-04-24 Mehrzweckvakzine gegen umhüllte viren ATE283065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/427,034 US6168787B1 (en) 1995-04-24 1995-04-24 Pluripotent vaccine against enveloped viruses
PCT/US1996/005731 WO1996033734A1 (en) 1995-04-24 1996-04-24 A pluripotent vaccine against enveloped viruses

Publications (1)

Publication Number Publication Date
ATE283065T1 true ATE283065T1 (de) 2004-12-15

Family

ID=23693219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913123T ATE283065T1 (de) 1995-04-24 1996-04-24 Mehrzweckvakzine gegen umhüllte viren

Country Status (8)

Country Link
US (2) US6168787B1 (de)
EP (1) EP0830140B1 (de)
JP (1) JPH11509521A (de)
AT (1) ATE283065T1 (de)
AU (1) AU708327B2 (de)
CA (1) CA2219339A1 (de)
DE (1) DE69633919T2 (de)
WO (1) WO1996033734A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19626614A1 (de) * 1996-07-02 1998-01-08 Immuno Ag Komplex aus Antigen und Zellbestandteil, Impfstoffzusammensetzung, welche den Komplex enthält, pharmazeutische Präparation sowie Verfahren zur Herstellung des Komplexes
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
CN1230444C (zh) * 1998-11-16 2005-12-07 德克萨斯州立大学董事会 含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途
US20070128209A1 (en) * 2005-03-21 2007-06-07 Network Immunology Inc. Vaccine based method for protection against hiv infection
US20060211012A1 (en) * 2005-03-21 2006-09-21 Network Immunology Inc. Mhc class ii as a preventive vaccine against hiv infection
WO2007112316A2 (en) * 2006-03-24 2007-10-04 Morton Donald L Mycobacterial immunotherapy for cancer treatment
CA2921063C (en) 2006-09-15 2020-01-28 Ottawa Hospital Research Institute Oncolytic rhabdovirus
CA2674244A1 (en) * 2006-12-28 2008-07-10 Saint Louis University Identification of multivalent viral envelope protein epitopes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030621A (en) * 1987-04-23 1991-07-09 Bystryn Jean Claude Shed melanoma antigen compositions
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
US5840317A (en) * 1989-11-03 1998-11-24 Morton; Donald L. Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
GB9201023D0 (en) 1992-01-17 1992-03-11 Medical Res Council Vaccines
US5651993A (en) 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US6218166B1 (en) * 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods

Also Published As

Publication number Publication date
DE69633919T2 (de) 2005-12-01
AU708327B2 (en) 1999-08-05
CA2219339A1 (en) 1996-10-31
AU5573196A (en) 1996-11-18
WO1996033734A1 (en) 1996-10-31
DE69633919D1 (de) 2004-12-30
US20030185806A1 (en) 2003-10-02
EP0830140A1 (de) 1998-03-25
US6168787B1 (en) 2001-01-02
EP0830140B1 (de) 2004-11-24
JPH11509521A (ja) 1999-08-24

Similar Documents

Publication Publication Date Title
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
SE8701413D0 (sv) Expression and purification of an htlv-iii gag/env gene protein
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
BR0107857A (pt) Proteìnas compreendendo regiões conservadas de antìgeno nhha de superfìcie de neisseria meningitidis
EA199800746A1 (ru) Способ генерации противовирусного иммунного ответа у человека или животного
EP0584266A4 (de) Karcinoembryonale antigen expremierende rekombinante viren und methoden ihrer anwendung.
DE60117978D1 (de) Modifizierung des hepatitis b kernantigens
DE69535018D1 (de) Papillomavirus vakzine
EP0841941A4 (de) Neuartige nicht pyrogene bakterienstämme und ihre verwendung
ATE362379T1 (de) Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv)
LV12085A (lv) Dendritiskas sunas stimulejosais faktors
DE60119734D1 (de) Hpv-e7 zur behandlung von menschlichem papillomavirus
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
ATE283065T1 (de) Mehrzweckvakzine gegen umhüllte viren
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
Karpenko et al. Results of phase I clinical trials of a combined vaccine against HIV-1 based on synthetic polyepitope immunogens
Delman et al. Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer
Naveed et al. Immune modulatory potential of anti-idiotype antibodies as a surrogate of foot-and-mouth disease virus antigen
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties